This technology is a method of generating an effective humoral and cellular immune response to poorly immunogenic targets.
Current biochemical methods used to generate antibody responses or T-cell activation using small molecules are sometimes non-immunogenic, leading to poor recognition by T-cell receptors and a weak immune response. T-cell receptor peptide recognition occurs in the context of MHC class molecules that present corresponding antigens on the cell surface. Fast and efficient coupling of small molecules to high molecular mass carriers at high ratios can potentially increase T-cell recognition.
This technology describes the use of bioorthogonal (‘Click’) chemistry reactions to couple immunogenic targets of interest to anchoring peptides within MHC molecule complexes. The coupling can be performed in vivo or in vitro by administering alkene anchoring peptides followed by an azide or tetrazine modified target of interest. Such reactions enable recognition of ‘clicked’ targets of interest by T-cell receptors, leading to an effective immune response against poor immunogenic targets.
Ilya Trakht, Ph.D.
IR CU21154, CU21177
Licensing Contact: Jerry Kokoshka